The recently described high sensitivity of the human eye to differentiate small angular
differences in linear polarization and evidence supporting its macular origin (Misson,
Anderson; 2017) suggests that human polarization sensitivity might be a useful diagnostic
tool for macular disease. This augments a previous study in which we demonstrated the ability
of the human visual system to detect isochromatic isoluminant polarization modulated pattern
stimuli (Misson et al 2015).
This is an exploratory 'proof-of-concept' study to determine the clinical value of
polarization pattern perception, PPP, in health and disease. We further propose that PPP
might be valuable for the diagnosis, monitoring and early detection of macular disease. The
latter includes common blinding conditions such as age related macular degeneration and
diabetic retinopathy. It is also intended to investigate the effect of cataracts and cataract
surgery on PPP: cataract surgery modifies the optics of the eye so might also modify PPP.
PPP is measured using a modification of the methodology described in (Misson et al 2015) and
(Misson, Anderson; 2017) whereby polarization modulated patterns are presented on a modified
LCD display. The observer's task is to report if they see an image and to describe the image.
Images comprise simple patterns or traditional optotypes. A standard set of images are
presented in pseudorandom order and the response recorded. A total score, the polarization
pattern perception score PPP is then determined from the number of images seen/identified. A
more refined metric, the polarization visual acuity pVA, will be derived from the response to
the optotype stimuli. These data are then compared to conventional tests of visual structure
and function including logMAR visual acuity, ocular examination and OCT scan data.
The study in anticipated to comprise:
Phase 1. Normative Evaluation: observational prospective cross-sectional.. A preliminary
normative study will be undertaken on staff members. The aim is to quantify normative values
in preparation for the clinical studies.
Hypotheses to be tested:
that healthy subjects can perceive polarization stimuli
that there is a threshold of polarization image resolution (pVA) analogous to visual
acuity. Normative PPP and pVA data will be collected.
Phase 2 Patient Group: observational Prospective cross-sectional / case-control.
Phase 2 subjects will comprise normals and patients with cataracts/pseudophakia and/or AMD,
other macular pathology, diabetic retinopathy..
The aim of this phase is to determine the effect, if any, of particular eye conditions on
pVA/PPP alone and in comparison with other test parameters.
Hypotheses to be tested:
that eye conditions affect pVA/PPP
that specific eye conditions have a selective effect on pVA/PPP
that pseudophakia affects pVA/PPP
Phase 3: Cataract pre-op v post op pVA/PPP: prospective interventional case-control.
Timescale:concurrent with Phase 2 A subset of the phase 2 cataract patients will undergo
cataract surgery according to clinical need. These patients are routinely reviewed 4 - 8
weeks post-op when the opportunity will arise to repeat pVA/PPP measurement. The fellow eye
will serve as a control / provide data for repeatability assessment.
The aims of this phase are
to determine the repeatability of pVA/PPP testing in a heterogeneous patient group
to determine the effect of cataract surgery on the pre-operative pVA/PPP results
to determine if pVA/PPP is a useful determinant of post-operative visual outcome.
Hypotheses:
that pVA/PPP testing is repeatable
that there is a difference in pVA/PPP pre and post cataract surgery
